On November 27, 2020, the third edition of our National Conference on Biosimilars entitled "Towards a biosimilar strategy for the National Health Systems" was held in a virtual format.
CHECK PROGRAM SEE VIDEOS OF THE PRESENTATIONS
PRESENTATIONS
Introduction
Joaquin Rodrigo
OPEN
Profit Sharing Program. The vision of hospital management
Dr. Rosa Bermejo Couple
OPEN
Successful experiences in promoting biosimilars as a clinical management measure
Vincent Alonso Nunez
OPEN
Clinical management, incentives and Biosimilars
Felix Wolf
OPEN
SNS Expenditure on Hospital Pharmacy and Investment in High Technology Equipment
Angel Sanchez Aristi
OPEN
Budget impact analysis of biosimilar medicines in the Spanish National Health System (2009-2022)
Manuel Garcia Goni
OPEN
SEFH-BIOSIM AWARDS
Winner
Preliminary results from an original to biosimilar adalimumab exchange program in inflammatory bowel disease
Noemi Rebollo Diaz, Nerea Martín Gutiérrez, José Germán Sánchez Hernández, José Fernando Muñoz Nuñez, Mª Concepción Piñero Pérez, Mª José Otero López
OPEN
Second prize
Evaluation of the effectiveness, safety in switching and economic savings between reference trastuzumab and biosimilar trastuzumab
Juan José García Albas, Severina Domínguez Fernández, Miguel Ángel Andrés Moralejo, Ana Santaolalla Sánchez, Marta Rosado Ancin, Carlos Martínez Martínez
OPEN
Biosimilar drugs in off-label indications: an efficient strategy
Berta Montero Pastor, Ismael Escobar Rodríguez
